New experimental Alzheimer’s drug shows potential after study shows slower cognitive decline
A study on Biogen's diranersen found it slowed cognitive decline and has promise in treating Alzheimer's disease, researchers found.
Comments 0
Log in to join the conversation.
No comments yet. Be the first to share your thoughts!